Get the Stockscreener App
0.7339
0.51%
0.0037
Maxcyte Inc Stock (MXCT) Forecast
The Maxcyte Inc (MXCT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.0803, representing a +183.46% increase from the current price of $0.7339. The highest analyst price target is $1.9486, and the lowest is $2.212.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MXCT Price Target
Average 1.1566
(+57.60% Upside)
Is Maxcyte Inc (MXCT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 17.57 | Buy |
| STOCH(9,6) | 12.51 | Buy |
| STOCHRSI(14) | 30.85 | Neutral |
| MACD(12,26) | -0.1731 | Sell |
| ADX(14) | 58.84 | Sell |
| William %R | -89.43 | Buy |
| CCI(14) | -50.83 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8103
Sell
|
0.831
Sell
|
| MA20 |
0.9847
Sell
|
0.9654
Sell
|
| MA50 |
1.302
Sell
|
1.2095
Sell
|
| MA100 |
1.4595
Sell
|
1.4213
Sell
|
| MA200 |
1.7315
Sell
|
1.8771
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MXCT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MXCT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 17.57 indicates that MXCT is oversold. This indicates that MXCT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 12.51 indicates that MXCT is oversold. This indicates that MXCT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.85 indicates that MXCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 58.84 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -50.83 indicates that MXCT is still oversold but not to an extreme extent.
Long-term MXCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Maxcyte Inc financial reports and earnings history, Maxcyte Inc (MXCT) stock could reach $6.1062 by 2030, $53.10 by 2040 and $84.48 by 2050. See the projected annual prices until 2050 of the Maxcyte Inc stock below:
- Maxcyte Inc (MXCT) is expected to reach an average price of $25.39 in 2035, with a high prediction of $27.27 and a low estimate of $26.38. This indicates an $3,360% rise from the last recorded price of $0.7339.
- Maxcyte Inc (MXCT) stock is projected to chart a bullish course in 2040, with an average price target of $54.22, representing an $7,288% surge from its current level. The forecast ranges from a conservative $10.91 to a sky-high $53.10.
- Our analysts predict Maxcyte Inc (MXCT) to jump 5,471% by 2045, soaring from $41.05 to an average price of $40.89, potentially reaching $41.26. While $41.05 is the low estimate, the potential upside is significant.
- Maxcyte Inc (MXCT) stock is expected to climb by 2050, reaching an average of $83.45, a $11,270% jump from its current level. However, a wide range of estimates exists, with high and low targets of $84.48 and $84.45, respectively, highlighting the market's uncertainty.
Maxcyte Inc Stock (MXCT) Year by Year Forecast
Maxcyte Inc Stock (MXCT) Price Forecast for 2026
The predicted value for Maxcyte Inc (MXCT) in 2026 is set at an average of $1.1566. Estimates vary from a peak of $2.1085 to a trough of $0.2047, indicating an +57.60% surge from the present price of $0.7339.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2026 | $1.4219 | $2.212 | $1.9486 | +93.75% |
| April, 2026 | $1.3452 | $1.2819 | $1.2187 | +83.29% |
| May, 2026 | $1.8118 | $1.9468 | $2.1085 | +146.87% |
| June, 2026 | $0.9984 | $1.1918 | $1.4584 | +36.04% |
| July, 2026 | $0.9317 | $0.6377 | $0.9851 | +26.95% |
| August, 2026 | $1.4783 | $0.9683 | $1.3033 | +101.43% |
| September, 2026 | $1.5115 | $1.3684 | $1.3199 | +105.96% |
| October, 2026 | $1.8081 | $1.7782 | $1.6048 | +146.37% |
| November, 2026 | $1.0848 | $1.5848 | $1.5481 | +47.81% |
| December, 2026 | $0.742 | $0.2047 | $0.8014 | +1.10% |
Maxcyte Inc Stock (MXCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Maxcyte Inc (MXCT) is $6.5773, with a high forecast of $12.80 and a low forecast of $0.3587. This indicates an +796.21% increase from the last price of $0.7339.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6754 | $0.3587 | $1.1653 | -7.97% |
| February, 2027 | $1.2188 | $0.3637 | $1.6271 | +66.07% |
| March, 2027 | $1.0455 | $0.8605 | $1.5355 | +42.46% |
| April, 2027 | $0.9789 | $0.5189 | $1.3622 | +33.38% |
| May, 2027 | $0.8823 | $0.7922 | $1.3322 | +20.22% |
| June, 2027 | $7.82 | $0.574 | $6.70 | +965.54% |
| July, 2027 | $5.5732 | $7.6732 | $7.0066 | +659.40% |
| August, 2027 | $10.15 | $7.3865 | $8.4264 | +1,283% |
| September, 2027 | $10.59 | $11.71 | $10.88 | +1,343% |
| October, 2027 | $11.66 | $9.6729 | $9.8263 | +1,488% |
| November, 2027 | $10.95 | $11.61 | $11.18 | +1,392% |
| December, 2027 | $13.84 | $10.94 | $12.80 | +1,785% |
Maxcyte Inc Stock (MXCT) Price Forecast for 2028
In 2028, Maxcyte Inc (MXCT) is projected to reach an average price of $11.15, with a high projection of $13.74 and a low estimate of $8.5612. This indicates an +1,419% rise from the last price of $0.7339.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.45 | $14.30 | $13.73 | +1,733% |
| February, 2028 | $13.68 | $13.41 | $13.01 | +1,764% |
| March, 2028 | $12.23 | $12.29 | $13.48 | +1,566% |
| April, 2028 | $13.07 | $13.13 | $13.04 | +1,681% |
| May, 2028 | $13.47 | $13.54 | $13.35 | +1,735% |
| June, 2028 | $12.62 | $13.82 | $13.74 | +1,620% |
| July, 2028 | $12.53 | $12.61 | $12.60 | +1,607% |
| August, 2028 | $11.07 | $11.10 | $11.58 | +1,409% |
| September, 2028 | $9.8848 | $11.14 | $10.90 | +1,247% |
| October, 2028 | $9.178 | $9.7024 | $9.6014 | +1,151% |
| November, 2028 | $8.3545 | $8.5612 | $9.1246 | +1,038% |
| December, 2028 | $8.8878 | $8.9711 | $8.6338 | +1,111% |
Maxcyte Inc Stock (MXCT) Price Forecast for 2029
The 2029 price forecast for Maxcyte Inc Stock (MXCT) is $7.5919 on average, with a high prediction of $9.081 and a low estimate of $6.1027. This represents an +934.45% increase from the previous price of $0.7339.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.8843 | $8.8911 | $9.081 | +1,111% |
| February, 2029 | $8.1475 | $8.6775 | $8.7176 | +1,010% |
| March, 2029 | $8.6407 | $8.1558 | $8.2707 | +1,077% |
| April, 2029 | $8.6739 | $8.7439 | $8.5473 | +1,082% |
| May, 2029 | $7.1805 | $7.6955 | $8.4272 | +878.40% |
| June, 2029 | $8.2787 | $7.4938 | $7.2571 | +1,028% |
| July, 2029 | $7.3069 | $7.6969 | $8.107 | +895.63% |
| August, 2029 | $6.5134 | $6.8661 | $6.8802 | +787.51% |
| September, 2029 | $6.2466 | $6.1027 | $6.1366 | +751.16% |
| October, 2029 | $6.5232 | $6.3349 | $6.5015 | +788.83% |
| November, 2029 | $6.6464 | $6.4067 | $6.3464 | +805.62% |
| December, 2029 | $6.2096 | $6.4696 | $6.4297 | +746.11% |
Maxcyte Inc Stock (MXCT) Price Forecast for 2030
Maxcyte Inc Stock (MXCT) is expected to reach an average price of $12.04 in 2030, with a high forecast of $21.89 and a low forecast of $2.1986. This signifies an +1,541% surge from the last price of $0.7339.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6461 | $5.5061 | $6.1062 | +533.07% |
| February, 2030 | $3.5193 | $3.8093 | $3.8844 | +379.54% |
| March, 2030 | $3.3426 | $3.6076 | $3.3417 | +355.45% |
| April, 2030 | $2.4258 | $2.6408 | $2.4092 | +230.53% |
| May, 2030 | $2.3823 | $2.4241 | $2.409 | +224.61% |
| June, 2030 | $2.1355 | $2.3156 | $2.2522 | +190.98% |
| July, 2030 | $2.312 | $2.2354 | $2.1237 | +215.03% |
| August, 2030 | $20.30 | $2.1986 | $18.47 | +2,666% |
| September, 2030 | $18.65 | $18.72 | $18.50 | +2,441% |
| October, 2030 | $22.80 | $19.51 | $21.89 | +3,007% |
| November, 2030 | $21.19 | $21.98 | $21.84 | +2,787% |
| December, 2030 | $21.94 | $20.42 | $21.82 | +2,889% |
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):